熱門資訊> 正文

和谐生物科学控股公司GAAP每股收益0.55美元，损失0.14美元，2.153亿美元的收入损失554万美元

2026-05-07 19:50

Harmony Biosciences Holdings, Inc.(HRMY) 0
歐朋公司(OPRA) 0
Beyond(BYON) 0

Harmony Biosciences Holdings, Inc. press release (HRMY): Q1 GAAP EPS of $0.55 misses by $0.14.
Revenue of $215.3M (+16.6% Y/Y) misses by $5.54M.
General and Administrative expenses were $32.5 million in the first quarter of 2026, as compared to $31.2 million for the same quarter in 2025, representing a 4% increase
Total Operating Expenses were $133.6 million in the first quarter of 2026, as compared to $96.5 million for the same quarter in 2025, representing a 38% increase

More on Harmony Biosciences Holdings, Inc.

Harmony Biosciences: Four More Wakix Years, Nothing Visible Beyond
Harmony Biosciences Holdings, Inc. (HRMY) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript
Harmony Biosciences Holdings, Inc. (HRMY) Q4 2025 Earnings Call Transcript
Harmony Bio spikes after new Wakix patent litigation
Harmony Biosciences targets $1B–$1.04B WAKIX revenue in 2026 while expanding late-stage CNS pipeline

推薦文章

風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。